Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OTIC

Otonomy

$14.35

1.05 (7.89%)

08:07
05/08/17
05/08
08:07
05/08/17
08:07
Recommendations
Otonomy analyst commentary at SunTrust »

Otonomy should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$13.30

0.15 (1.14%)

17:05
05/04/17
05/04
17:05
05/04/17
17:05
Hot Stocks
Otonomy sees FY17 GAAP operating expenses $103M-$108M »

Otonomy reaffirms its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

OTIC

Otonomy

$13.30

0.15 (1.14%)

17:03
05/04/17
05/04
17:03
05/04/17
17:03
Earnings
Otonomy reports Q1 EPS (89c), consensus (86c) »

Cash, cash equivalents,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

Over a month ago
OTIC

Otonomy

$13.40

-0.45 (-3.25%)

07:37
03/09/17
03/09
07:37
03/09/17
07:37
Recommendations
Otonomy analyst commentary at SunTrust »

Otonomy should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$13.40

-0.45 (-3.25%)

06:24
03/09/17
03/09
06:24
03/09/17
06:24
Recommendations
Otonomy analyst commentary at Piper Jaffray »

Otonomy remains a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$15.35

-0.05 (-0.32%)

16:28
03/02/17
03/02
16:28
03/02/17
16:28
Earnings
Otonomy reports Q4 EPS (88c), consensus (93c) »

Cash Position: Cash, cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 06

    Mar

Over a quarter ago
OTIC

Otonomy

$15.65

-0.25 (-1.57%)

07:31
01/19/17
01/19
07:31
01/19/17
07:31
Hot Stocks
Otonomy initiates patient enrollment in Phase 2 clinical trial of OTO-104 »

Otonomy announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$17.75

-0.2 (-1.11%)

14:42
01/09/17
01/09
14:42
01/09/17
14:42
Recommendations
Otonomy analyst commentary at SunTrust »

Otonomy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

OTIC

Otonomy

$17.75

-0.2 (-1.11%)

14:41
01/09/17
01/09
14:41
01/09/17
14:41
Hot Stocks
Otonomy reports data on Otiprio launch, sees sNDA submission in 1H17 »

Otonomy provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

OTIC

Otonomy

$16.20

0.55 (3.51%)

07:20
01/05/17
01/05
07:20
01/05/17
07:20
Hot Stocks
Otonomy Otiprio Phase 3 clinical trial met primary endpoint »

Otonomy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.